Jeff Yass’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$311K Sell
8,700
-800
-8% -$28.1K ﹤0.01% 10870
2026
Q2
$298K Buy
9,500
+2,000
+27% +$84.4K ﹤0.01% 11052
2026
Q1
$415K Sell
7,500
-10,100
-57% -$481K ﹤0.01% 10125
2025
Q4
$658K Buy
17,600
+12,400
+238% +$504K ﹤0.01% 8178
2025
Q3
$210K Buy
+5,200
New +$172K ﹤0.01% 10890
2022
Q4
– Sell
-15,000
Closed -$199K – 13337
2022
Q3
$199K Buy
+15,000
New +$259K ﹤0.01% 10850
2019
Q3
– Sell
-6,600
Closed -$210K – 10646
2019
Q2
$210K Buy
+6,600
New +$207K ﹤0.01% 9042

Other funds holding PAHC

Jeff Yass's PAHC Position: Q3 2026 in Review

Jeff Yass increased its Phibro Animal Health (PAHC) stake by 89% in Q3 2026, buying an estimated $341K and bringing the position to 20,606 shares worth $736K. The position accounts for ﹤0.01% of the portfolio, ranked #8742.

Jeff Yass first reported a position in PAHC in Q2 2014 and has held it in 24 quarters since. The position peaked at $1.9M in Q3 2025. 233 funds tracked by Wall St. Rank hold PAHC as of Q3 2026.

  • Jeff Yass held 20,606 shares of Phibro Animal Health worth $736K as of Q3 2026.
  • Jeff Yass bought 9,702 Phibro Animal Health shares in Q3 2026, an estimated $341K.
  • Phibro Animal Health made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #8742 holding.
  • Jeff Yass first reported a position in Phibro Animal Health in Q2 2014 and has held it in 24 quarters since.
  • Jeff Yass's Phibro Animal Health position peaked at $1.9M in Q3 2025.
  • 233 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.